文献速递胸部介入技术与安全CT

机器人辅助CT引导经胸肺活检首次人体研究

First-in-human pilot study of a robotic-assisted system for image-guided trans-thoracic lung biopsy: Clinical feasibility and exploratory post-hoc AI trajectory analysis.
PubMed 文献 · Eur J Radiol · 2026-07-16

本研究为前瞻性单中心临床试验,纳入30例患者,评估ANT-C患者安装式机器人针引导平台在局麻下CT引导经胸肺活检的技术可行性与临床成功率。结果显示技术成功率为93.3%,临床成功率为100%,操作时间与辐射剂量随经验积累显著下降,无重大并发症。

要点

  • 30例患者均成功获取足够组织用于完整病理与分子检测,临床成功率达100%。
  • 技术成功率93.3%,操作时间从61.4分钟降至30.5分钟,辐射剂量随之下降。
  • 仅见无症状病灶周围出血和微量气胸等轻微自限性A级不良事件。

核心结论

  • ANT-C机器人系统在清醒患者中具有临床可行性和技术可行性。
  • AI自动路径排序代价函数在整合到实时工作流程前需进一步优化。

研究设计与样本

  • 病灶中位大小为24 mm,操作由介入放射科医师在局麻下执行CT引导经胸肺活检。
  • AI路径规划由NDAnalyzer软件以平行盲法生成替代路径,不影响实际临床操作。

关键影像表现/征象

  • 轻微自限性A级不良事件仅表现为无症状病灶周围出血和微量气胸。

诊断标准与关键数值

  • 技术成功率为93.3%,临床成功率为100%,所有病例均成功获取足够组织标本。
  • 中位操作时间从前10例的61.4分钟降至后10例的30.5分钟。
  • 中位总辐射剂量从前十分位数的427.3 mGy·cm降至后十分位数的303.7 mGy·cm。
  • 操作者所选路径与最接近的自动替代路径之间的中位角度偏差仅为3.5°。

临床应用与阅片要点

  • 机器人辅助穿刺平台可在局麻下为清醒患者完成经胸肺活检,组织获取充分。
  • 操作熟练后可显著缩短操作时间并降低辐射剂量。
  • AI自动路径与操作者实际路径角度偏差小,提示未来有辅助路径规划潜力。

局限性

  • 前瞻性单中心临床试验,样本量仅30例。
  • AI路径分析为事后探索性分析,且平行盲法运行,未参与实时操作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND & OBJECTIVE: This prospective, single-center clinical trial evaluated the technical feasibility and clinical success of the Automatic Needle Targeting (ANT-C) patient-mounted robotic needle-guidance platform for CT-guided trans-thoracic lung biopsy under local anesthesia, incorporating an exploratory post-hoc geometric analysis of parallel artificial intelligence path planning via the NDAnalyzer software.

MATERIALS & METHODS: Out of thirty-one recruited patients, one was excluded due to on-table lesion resolution, leaving a final cohort of thirty evaluable subjects with a median nodule size of 24 mm. While interventional radiologists executed target acquisition using independently planned trajectories, the automated software generated alternative paths in a parallel, blinded fashion to ensure zero clinical influence on the live procedure.

RESULTS: The platform demonstrated a high technical success rate of 93.3% and a 100% clinical success rate, successfully harvesting adequate tissue cores for full histopathological and molecular profiling in all cases. Operational efficiency improved significantly as operators gained familiarity, with median procedural durations decreasing from 61.4 min in the first ten cases to 30.5 min in the final ten cases. Concurrently, median total radiation exposure significantly decreased from 427.3 mGy·cm to 303.7 mGy·cm between the early and late deciles. No major complications occurred, and minor, self-limiting Grade A adverse events were limited to asymptomatic perilesional hemorrhage and trace pneumothoraces. Furthermore, exploratory modeling revealed a median angular deviation of only 3.5° between the operator's selected path and the closest automated alternative.

CONCLUSION: The robotic system is clinically viable and technically feasible for awake patients, though the AI's automated path-ranking cost-function requires further refinement prior to live workflow integration.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Tan, Alfred, Leong, et al. First-in-human pilot study of a robotic-assisted system for image-guided trans-thoracic lung biopsy: Clinical feasibility and exploratory post-hoc AI trajectory analysis. Eur J Radiol. 2026. PMID: 42492116. doi:10.1016/j.ejrad.2026.113089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。